Platelet Shaker Global Market Report 2024

The platelet shaker market size has grown strongly in recent years. It will grow from $2.9 billion in 2023 to $3.11 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to biomedical and life sciences research, clinical diagnostics, and blood testing, driven by the rising incidence of hematological disorders.

The platelet shaker market size is expected to see strong growth in the next few years. It will grow to $4.12 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to the expanding biotechnology and pharmaceutical sectors, increased demand in clinical and pathology labs, a rise in point-of-care testing, a focus on personalized medicine, and the emergence of academic and research collaborations. Major trends in the forecast period include customization for research needs, sustainability and energy efficiency, collaborations for technological advancements, expansion of biopharmaceutical research, and market penetration in emerging economies.

The anticipated increase in blood-related disorders is set to drive the growth of the platelet shaker market in the forthcoming period. Blood-related diseases encompass conditions affecting various blood components, compromising their proper functioning. Platelet shakers play a vital role in ensuring the uniform dispersion and suspension of platelets during blood transfusions, particularly in treating or preventing blood disorders. For example, in 2023, as reported by the Leukemia & Lymphoma Society, an estimated 184,720 individuals are expected to receive diagnoses of leukemia, lymphoma, or myeloma. Moreover, projections indicate around 1,958,310 new cancer cases in the US in 2023, with leukemia, lymphoma, and myeloma cases expected to represent 9.4% of these diagnoses, resulting in approximately 57,380 deaths. Thus, the surge in blood-related disorders is a significant driver propelling the growth of the platelet shaker market.

The escalating incidence of dengue cases is projected to fuel the expansion of the platelet shaker market in the foreseeable future. Dengue, caused by the dengue virus transmitted through infected Aedes mosquitoes, is a viral infectious disease. Platelet shakers play a critical role in maintaining platelet quality and functionality during storage, particularly crucial for dengue patients requiring platelet transfusions to prevent or manage bleeding. For instance, according to the World Health Organization, in 2022, the Region of the Americas reported 3,123,752 cases of arboviral diseases, with dengue accounting for 2,809,818 (90%) of these cases - an exponential increase compared to 2021. Hence, the mounting incidence of dengue cases significantly contributes to the expansion of the platelet shaker market.

Regulatory compliance challenges are poised to emerge as a significant restraint in the future for the platelet shaker market. The need for consistent adherence to evolving regulations may hinder innovation and market entry, potentially leading to market consolidation and less competitive pricing for end-users. For instance, in 2021, the COVID-19 pandemic compelled life sciences companies to expedite product development while ensuring compliance with stringent regulatory mandates. Consequently, these regulatory compliance challenges are expected to exert a driving force on the platelet shaker market.

Key players within the platelet shaker market are directing their efforts towards developing innovative products, notably platelet agitator monitoring systems, to offer dependable services to their clientele. These monitoring systems provide real-time data on agitation speed and cycle count, enabling reset functionality for the cycle count and ensuring adherence to recommended storage conditions, including continuous and gentle agitation. For example, in March 2021, Helmer Scientific INC, a US-based enterprise specializing in the design, production, and distribution of medical and laboratory refrigeration equipment, introduced AgiTrak - a platelet agitator monitoring system integrated within Pro Line incubator storage systems. The Pro Line platelet agitators incorporate motion alarms that, when integrated into the platelet incubators, enable AgiTrak to monitor agitation. In the event of prolonged agitation cessation, the incubator's i.C3 interface triggers an alarm, ensuring staff awareness and event logging. Users can access agitator settings and status in real-time via the i.C3 interface, providing essential information on agitation, cycle count, and diagnostics, thereby enhancing platelet storage management.

In May 2023, Trane Technologies Plc, an Ireland-based manufacturing company focused on heating, ventilation, air conditioning (HVAC), and refrigeration systems, acquired Helmer Scientific Inc. for an undisclosed amount. This strategic move is anticipated to enable Trane Technologies to broaden its presence in various sectors of the economy, particularly the rapidly growing life sciences and clinical health markets, by offering climate innovation and temperature-control solutions. The acquisition enhances Trane Technologies' precision temperature management capabilities, complementing its existing portfolio of life science solutions and knowledge under the FARRAR brand. Helmer Scientific Inc., the US-based company acquired, specializes in manufacturing platelet shakers and other laboratory equipment.

Major companies operating in the platelet shaker market report are Thermo Fisher Scientific Inc., Fresenius Kabi AG, Sartorius AG, Eppendorf SE, JP Selecta SA, Sarstedt AG & Co. KG, Meditech Technology Co. Ltd., Labtron Equipment Ltd., Helmer Scientific Inc., KW Apparecchi Scientifici, Lmb Technologie GmbH, Azer Scientific Inc., Remi Electrkotecnic Limited, Boekel Scientific, Terumo Penpol Limited, Cryo Diffusion s.a.s., LW Scientific Inc., Benchmark Scientific Inc., Snijders Labs, Zenith Lab (Jiangsu)Co Ltd., Digisystem Laboratory Instruments Inc., Enlake Enterprises Pty Ltd., Labcold Ltd., Thermoline Scientific Pty Ltd., Fanem Ltd.

North America was the largest region in the platelet shaker market in 2023. The regions covered in the platelet shaker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa The countries covered in the platelet shaker market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The platelet shaker market consists of sales of rotators, mixers, and platelet incubators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The main types of platelet shakers are benchtop platelet shakers, floor-standing platelet shakers, and portable platelet shakers. Benchtop platelet shakers are devices intended to produce a smooth and regulated shaking action to promote proper oxygen transport to the platelets. They come in various capacities, including small, medium, and large, and find applications in blood banks, hospitals and diagnostic centers, academic and research institutes, and other relevant settings.

The platelet shakers market research report is one of a series of new reports that provides platelet shakers market statistics, including platelet shakers industry global market size, regional shares, competitors with a platelet shakers market share, detailed platelet shakers market segments, market trends and opportunities, and any further data you may need to thrive in the platelet shakers industry. This platelet shakers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.